InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Bourdow Carrie L., Chairman & CEO. Insider active across 3 companies, notably TREVENA INC. In total, 13 reports have been published. Total volume traded: €170k. The latest transaction was disclosed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations13 total
040,000 shares0
Common Stock
SEC:0001485003-22-000081:0·
€20,71833,546 shares@ €0.617613.0% of flow
Common Stock
SEC:0001192482-21-000767·
€20,71833,546 shares@ €0.61766.5% of flow
Common Stock
SEC:0001192482-21-000767:0·
€53,79593,561 shares@ €0.57533.9% of flow
Common Stock
SEC:0001879785-21-000031·
€53,79593,561 shares@ €0.57516.9% of flow
Common Stock
SEC:0001879785-21-000031:0·
01,250,000 shares0
Common Stock
SEC:0001879785-21-000027·
01,250,000 shares0
Common Stock
SEC:0001879785-21-000027:0·
€785777 shares@ €1.0106100.0% of flow
Ordinary Shares
SEC:0001104659-21-100287·
€785777 shares@ €1.010650.0% of flow
Ordinary Shares
SEC:0001104659-21-100287:0·
017,500 shares0
Ordinary Shares
SEC:0001104659-21-098426·
017,500 shares0
Ordinary Shares
SEC:0001104659-21-098426:0·
€84,28456,200 shares@ €1.499753.1% of flow
Common Stock
SEC:0001192482-21-000576·
Ideal exit: 25 Mar 2022 (T+270)
€84,28456,200 shares@ €1.499726.5% of flow
Common Stock
SEC:0001192482-21-000576:0·
Ideal exit: 25 Mar 2022 (T+270)
13 of 13 declarations
About Bourdow Carrie L.
Carrie L. Bourdow is President and CEO of TREVENA INC, Nabriva Therapeutics plc, and Sesen Bio, Inc. She plays a key role in the strategic direction of these companies, participating in key decisions that influence their development. Her expertise in the biopharmaceutical sector is valuable to the boards, enabling these companies to navigate effectively in a competitive environment.
